Teva Pharmaceutical Industries Ltd (TEVA.N)
Thu, Aug 2 2018
TEL AVIV Teva Pharmaceutical Industries on Thursday raised its profit outlook for 2018 after reporting a smaller than expected drop in second-quarter net profit, but its shares tumbled eight percent on disappointment over its unchanged revenue outlook.
* Company still sees FDA approval of migraine drug mid-September
TEL AVIV, Aug 2 Israel's heavily indebted Teva Pharmaceutical Industries reported a smaller than-expected drop in second-quarter profit on Thursday and raised its profit outlook for the full year.
* ANNOUNCED THAT FDA HAS APPROVED ACTAVIS (TEVA) GENERIC VERSION OF UCERIS
JERUSALEM Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay.
JERUSALEM, May 23 Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay.
JERUSALEM, May 23 Israeli drugmaker Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as early as mid-September, after an initial delay.
* TEVA PHARMACEUTICAL INDUSTRIES LTD - PRESCRIPTION DRUG USER FEE ACT (PDUFA) ACTION DATE FOR FREMANEZUMAB IS SET FOR SEPTEMBER 16
May 15 Warren Buffett's Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd , and confirmed it has become Apple Inc's second-largest shareholder.
* TEVA CANADA ANNOUNCES THE LAUNCH OF TEVA-CYCLOSPORINE® OPHTHALMIC EMULSION, THE FIRST GENERIC VERSION OF RESTASIS® IN CANADA FOR THE TREATMENT OF DRY EYE DISEASE
- Tracking David Abrams' Abrams Capital Management Portfolio - Q2 2018 Update
- Roche: Details On Growing Through The Patent Cliff (Part 2 Of 2)
- Recro Pharma: Cautious Cheer Following Earnings
- Your Daily Pharma Scoop: Foundation Promising, Paratek Moves Up, Ovid Down
- Novartis: Business Transformation In Progress
- Rose Portfolio Options: Covered Puts And Calls - Nothing Naked